2017 ASH MHM: Focus on Leukemia – Anjali Advani, MD
582 views · Published 24 March 2017 · 1:30 · Indexed 8 November 2026
Channel: American Society of Hematology · 2017 · Nonprofits & Activism
Anjali Advani, MD, discusses exciting updates in leukemia, including newly approved drugs (blinatumomab) and drugs in the pipeline (inotuzumab). Leukemia is one of the core malignancies covered at the ASH Meeting on Hematologic Malignancies (MHM), which is structured in a “How I Treat” format that provides an ideal learning experience for physicians who treat leukemia. The meeting’s expert speakers discuss specific patient cases, present cutting-edge scientific data, and provide insight into how new treatments can be incorporated upfront. Learn more about the ASH Meeting on Hematologic Malignancies at http://www.hematology.org/Malignancies/
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding